TCG Crossover GP I, LLC 13D and 13G filings for Tyra Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-06 6:02 pm Purchase |
2025-02-27 | 13G | Tyra Biosciences, Inc. TYRA |
TCG Crossover GP I, LLC | 2,898,103 5.700% |
2,898,103 (New Position) |
Filing |